- Empirical evaluation of the implementation of the EMA guideline on ...🔍
- Specification of mixed models for longitudinal data in study protocols🔍
- Layman's abstract for paper on empirical evaluation of the ...🔍
- 64. Jahrestagung der Deutschen Gesellschaft für ...🔍
- Guideline on the clinical evaluation of anticancer medicinal products🔍
- Commentary on the draft revised guideline on the environmental risk ...🔍
- Modelling and simulation🔍
- Scientific and regulatory evaluation of empirical pharmacometric ...🔍
Empirical evaluation of the implementation of the EMA guideline on ...
Empirical evaluation of the implementation of the EMA guideline on ...
The primary analysis model is defined unambiguously. This requirement applies to mixed models for longitudinal data handling missing data implicitly.
Specification of mixed models for longitudinal data in study protocols
Empirical evaluation of the implementation of the EMA guideline on missing ... To evaluate the compliance with the EMA guideline, we evaluated the ...
Empirical evaluation of the implementation of the EMA guideline on ...
Empirical evaluation of the implementation of the EMA guideline on missing data in confirmatory clinical trials: Specification of mixed models for longitudinal ...
Specification of mixed models for longitudinal data in study protocols
Empirical evaluation of the implementation of the EMA guideline on missing data in confirmatory clinical trials: Specification of mixed ...
Specification of mixed models for longitudinal data in study protocols
However, for at least 69% of all evaluated trials, a definite evaluation of the compliance with the EMA guideline was possible. This outsourcing ...
Layman's abstract for paper on empirical evaluation of the ...
Not a single protocol specified all evaluation items as required by the EMA guideline. The fixed/random effects, the covariance structure and ...
64. Jahrestagung der Deutschen Gesellschaft für ... - GMS
Empirical evaluation of the implementation of the EMA guideline on missing data in confirmatory clinical trials: specification of mixed models for ...
Empirical evaluation of the implementation of the EMA guideline on ...
Article: Empirical evaluation of the implementation of the EMA guideline on missing data in confirmatory clinical trials: Specification of mixed mo.
Guideline on the clinical evaluation of anticancer medicinal products
Nonclinical evaluation for anticancer pharmaceuticals EMEA/CHMP/ICH/646107/2008 (ICH. S9). •. Points to Consider on Multiplicity Issues in ...
Commentary on the draft revised guideline on the environmental risk ...
The European Medicines Agency (EMA) has released for public consultation a draft revision of the guideline on the environmental risk assessment ...
Modelling and simulation: questions and answers
The European Medicines Agency's (EMA) provides an overview of its position on specific issues related to modelling and simulation in the form of questions and ...
Scientific and regulatory evaluation of empirical pharmacometric ...
Although the EMA guidance on population‐PK models describes mainly what the sponsor should report from the modeling exercise, this indirectly poses requirements ...
Evaluating the re-identification risk of a clinical study report ... - Trials
European Medicines Agency, “External guidance on the implementation of the European Medicines Agency policy on the publication of clinical ...
Data-sharing and re-analysis for main studies assessed by the ... - Vivli
Data-sharing and re-analysis for main studies assessed by the European Medicines Agency – a cross-sectional study on European Public Assessment Reports.
Guidance and Q&As - EMA - EU Clinical Trials
Certain countries in the EU or the Economic European Area (EEA) may require that data is provided in a commonly understood language in the medical field, such ...
Guideline on the evaluation of anticancer medicinal products in man
should also refer to other relevant European and ICH guidelines on the conduct of clinical trials, ... While adequate empirical comparative data form the basis of.
EMA versus US-FDA regulatory requirements regarding ... - DGRA
A couple of alternative study designs are given by the guideline as well, such as a) parallel design for drug substances with a "very long half-life" [7] ...
What To Know Before Embarking On Your EMA Policy 0070 ...
EMA Policy 0070 (otherwise known as Clinical Data Publication, or CDP), is a policy implemented by the European Medicines Agency (EMA) that governs the ...
Investigating Best Practices for Ecological Momentary Assessment
While EMA allows researchers to gain valuable insights into dynamic behavioral processes, the need for frequent self-reporting can be burdensome ...
Reporting guidelines - EQUATOR Network
... EMA Studies (CREMAS) ... Reporting guidelines for implementation research on nurturing care interventions designed to promote early childhood development